In February 2014, Merck Sharp & Dohme Corp. (“MSD”) brought proceedings against Paranova Läkemedel AB (“Paranova”), alleging that Paranova was violating MSD’s right as an exclusive licensee of the European patent EP 0 595 935 (“EP 935”) by taking preparatory measures for parallel importation. MSD applied for a permanent injunction and corrective measures as well as a preliminary injunction. The Stockholm District Court granted a permanent injunction and held that the approved application for authorization of parallel importation from the European Medicines Agency (EMA) was considered to constitute imminent infringement.

A full summary of this case has been published on Kluwer IP Law.


_____________________________

To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.


Kluwer IP Law

The 2022 Future Ready Lawyer survey showed that 79% of lawyers think that the importance of legal technology will increase for next year. With Kluwer IP Law you can navigate the increasingly global practice of IP law with specialized, local and cross-border information and tools from every preferred location. Are you, as an IP professional, ready for the future?

Learn how Kluwer IP Law can support you.

Kluwer IP Law
This page as PDF